Betnovate RD (ready diluted) 0.025% w/w Cream betamethasone (as valerate)

Similar documents
Package leaflet: Information for the user

Cutivate 0.05% w/w Cream fluticasone propionate

Patient Leaflet : Information for the user Locoid Cream 0.1% w/w Hydrocortisone butyrate

Package leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Hydrocortisyl Skin Cream 1% Hydrocortisone

Package leaflet: Information for the user. Fluticrem 0.05% cream Fluticasone propionate

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the patient. Mometasone furoate 0.1%w/w Ointment (mometasone furoate)

Package leaflet: Information for the patient. Eczibet 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Package leaflet: Information for the patient. IsotrexIN Gel erythromycin 2% and isotretinoin 0.05%

PACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package leaflet: Information for the user. Monovo 1 mg/g cutaneous emulsion. mometasone furoate

PACKAGE LEAFLET 1 April 2017

1.3.1 PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide

Package leaflet: Information for the user. Zoviduo 50 mg/g and 10 mg/g cream. Aciclovir and Hydrocortisone

PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide

FASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR

Package leaflet: Information for the patient UNITED KINGDOM Feldene 5mg/g Gel piroxicam

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Monovo 1 mg/g ointment. Mometasone furoate

Zatamil Mometasone furoate 0.1% w/w

Package Leaflet: Information for the user. RELENZA 5 mg per dose, inhalation powder, pre-dispensed zanamivir

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Respules 1 mg/2 ml Nebuliser Suspension budesonide

PATIENT INFORMATION LEAFLET. Urea 10% w/w Cream

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Elements for a Public Summary

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tacrolimus 0.1% Ointment Tacrolimus

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

BETNOVATE Betamethasone 17-valerate

PATIENT INFORMATION LEAFLET. Naseptin Nasal Cream chlorhexidine dihydrochloride and neomycin sulfate

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

1 What Flixonase is and what it is used for

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

BETNOVATE SKIN CREAM. Betamethasone Valerate Cream IP QUALITATIVE AND QUANTITATIVE COMPOSITION

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Patient Information Leaflet

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

1. WHAT IS CANESTEN HC CREAM AND WHAT IS IT USED FOR?

Easyhaler Beclometasone 200 micrograms/dose inhalation powder

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1%

1g cream or ointment contains 1 mg methylprednisolone aceponate.

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

PATIENT INFORMATION LEAFLET

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Beclometasone dipropionate

NOVASONE Mometasone furoate

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid)

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide)

Package leaflet: Information for the user. CLARELUX 500 microgram/g cutaneous foam in pressurised container (Clobetasol propionate)

Package leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

Package leaflet: Information for the patient

Zinnat can also be used: to treat Lyme disease (an infection spread by parasites called ticks).

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the user. Carmellose sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. PROSCAR 5 mg Film-coated Tablets (finasteride)

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

Ventolin Accuhaler 200 micrograms salbutamol sulfate

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

Unofficial translation of the German package leaflet. Package leaflet: Information for the user

FLIXOTIDE CFC-FREE INHALER and JUNIOR CFC-FREE INHALER ['PUFFER'] Fluticasone propionate Consumer Medicine Information

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

Package leaflet: Information for the user. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate

Package Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Budesonide Teva 0.5 mg/2 ml Nebuliser Suspension Budesonide

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package leaflet: Information for the patient. Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets Hydrocortisone

Zovirax Ophthalmic (eye) Ointment Acyclovir

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

Package leaflet: Information for the user. Qutenza 179 mg cutaneous patch capsaicin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

Elidel Cream Pimecrolimus 1 % w/w Consumer Medicine Information

Package leaflet: Information for the patient

Motens 2 mg and 4 mg Tablets lacidipine

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

2. What you need to know before you take DDAVP/Desmopressin Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Transcription:

Package Leaflet: Information for the User Betnovate RD (ready diluted) 0.025% w/w Cream betamethasone (as valerate) Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. What is in this leaflet: 1 What Betnovate RD is and what it is used for 2 What you need to know before you use Betnovate RD 3 How to use Betnovate RD 4 Possible side effects 5 How to store Betnovate RD 6 Contents of the pack and other information 1 What Betnovate RD is and what it is used for The name of your medicine is Betnovate RD Cream. Betnovate RD (Ready Diluted) 0.025% Cream contains the active substance betamethasone valerate. It belongs to a group of medicines called steroids that help to reduce redness, swelling and irritation of the skin. They should not be confused with anabolic steroids misused by some body builders and athletes and taken as tablets and injections. Betnovate RD is used to help reduce the redness and itchiness of certain skin problems, such as: eczema prurigo nodularis (itchy nodules on the arms or legs) psoriasis (thickened patches of inflamed, red skin, often covered by silvery scales), excluding widespread plaque psoriasis. lichen simplex chronicus (patches of thickened, itchy skin, caused by scratching) lichen planus (a skin disease that causes itchy, reddish-purple, flat-topped bumps on the wrists, forearms or lower legs) seborrhoeic dermatitis (a red, scaly, itchy rash that develops on the face, scalp, chest and back) discoid lupus erythematosus (a disease of the skin most often affecting the face, ears and scalp causing scarring and increased sensitivity of the affected skin to sunlight) skin rash due to allergy or a substance that irritates your skin (irritant and allergic contact dermatitis)

used in addition to oral or injectable steroids for erythroderma (inflammation, redness and scaling of the skin over most of the body) insect bites prickly heat dermatitis. For children over the age of one year Betnovate RD is used for dermatitis that has not responded to milder steroid creams or ointments. RD stands for Ready Diluted, it contains less active ingredient than Betnovate. It is used: for milder skin problems to keep your skin problem under control after Betnovate has improved it. 2 What you need to know before you use Betnovate RD Do NOT use Betnovate RD: if you are allergic (hypersensitive) to betamethasone valerate or any of the other ingredients of Betnovate RD (listed in Section 6). on a child under 1 year of age. to treat any of the following skin problems, it could make them worse: - acne - rosacea (a facial skin condition where the nose, cheeks, chin, forehead or entire face are unusually red, with or without tiny visible blood vessels, bumps (papules) or pus-filled bumps (pustules)) - spotty red rash around your mouth (perioral dermatitis) - itchy skin which is not inflamed - itching around the anus or genitals (penis or vagina) - infected skin (unless the infection is being treated with an anti-infective medicine at the same time) - widespread plaque psoriasis. Do not use if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before using Betnovate RD. Stop using Betnovate RD and tell your doctor as soon as possible if: you find that you develop an allergic reaction, the area being treated becomes infected, or if you are being treated for psoriasis and you get raised bumps with pus under the skin (pustular psoriasis). Warnings and precautions Talk to your doctor or pharmacist before using Betnovate RD Only use an airtight dressing over this medicine if your doctor has told you to. If you are applying Betnovate under an airtight dressing, including a child s nappy, make sure that the skin is cleansed before a dressing is applied to prevent infections. These dressings make it easier for the active ingredient to pass through the skin. It is possible to accidentally end up using too much. Prolonged use with occlusive dressings may cause the body to produce lower levels of the hormone cortisol than normal. Take care when applying Betnovate to the face over a long period of time as it may cause skin thinning.

Take care when applying Betnovate to the eyelids to make sure it does not get into your eye as there may be a risk of developing glaucoma. If you are using this for a prolonged period of time there is a possibility you may develop a cataract (clouding of the eye s lens). If you have psoriasis, your doctor will want to see you more often. Take care if you are using large quantities for a prolonged period or you are treating a large area of the body. This medicine may be absorbed through the skin and into your blood stream which can result in the following symptoms of hypercortisolism developing; stretch marks, the appearance of blood vessels under the surface of your skin, increased body hair growth, changes in skin colour, skin thinning, weight gain or rounding of the face (moon face). Only use Betnovate RD for as long as your doctor recommends. If your condition does not improve with 2 4 weeks of treatment, speak to your doctor. Take care if you have eczema around a leg ulcer, use of a topical corticosteroid may increase the risk of an allergic reaction or an infection around the ulcer. Children Avoid continuous treatment for longer than 3 weeks or use of occlusion (including nappies) in infants and children under the age of 3 years as adrenocortical suppression (where the body produces lower levels of the hormone cortisol than normal) and growth retardation may occur. Do not use this medicine on a child under the age of 1. Other medicines and Betnovate RD Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicine. Some medicines may affect how Betnovate RD works or make it more likely that you ll have side effects. Examples of these medicines include: Ritonavir and itraconazole Tell your doctor or pharmacist if you are taking any of these. There are other medicines whihc may have a similar effect. It s therefore very important to tell your doctor or pharmacist if you re taking any other medicines, if you ve taken any recently, or if you start taking a new one. This includes medicines bought without a prescription.

Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. You should not use this medicine if you are pregnant or breast-feeding unless your doctor has recommended you to do so. If you do use Betnovate RD when breastfeeding, don t use Betnovate RD on your breast area to ensure that the baby does not accidentally get Betnovate RD in their mouth. Betnovate RD contains chlorocresol and cetostearyl alcohol Betnovate RD contains chlorocresol and cetostearyl alcohol; chlorocresol may cause allergic reactions and cetostearyl alcohol may cause local skin reactions (e.g. contact dermatitis). 3 How to use Betnovate RD Always use this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Using this medicine You usually apply Betnovate RD 1 to 3 times a day. This may be reduced as your skin begins to get better. This cream is for use on your skin only. Do not use more than the amount prescribed for you. If you are using an emollient (moisturising) preparation allow time for Betnovate RD to be absorbed after each application before applying the emollient. Do not use on large areas of the body for a long time (such as every day for many weeks or months) - unless your doctor tells you to. If your eczema flares up frequently, your doctor may suggest that you use a less frequent dose of Betnovate once your eczema is under control, to help stop your eczema from coming back. For example, you may be advised to apply a thin film of Betnovate once daily, two times a week to areas of skin which have been affected by eczema, or to those areas where it is likely to reappear. The germs that cause infections like warm, moist conditions under bandages or dressings so always clean the skin before a fresh dressing is put on. If you are applying the cream on someone else make sure you wash your hands after use or wear disposable plastic gloves. If your skin problem does not improve in 2 4 weeks, talk to your doctor. Guidance on how to apply the cream 1 Wash your hands. 2 Apply the cream sparingly to the affected area. 3 Unless you are meant to apply the cream to your hands as a part of the treatment, wash them again after using the cream.

Use in children Do not use it on children under 1 year of age. Avoid continuous treatment for longer than 3 weeks or use of occlusion (including nappies) in infants and children under the age of 3 years. If you have psoriasis If you have thick patches of psoriasis on your elbows or knees, your doctor may suggest applying the cream under an airtight dressing. It will only be at night to help the cream to start working. After a short period of time you will then apply the cream as normal. If you apply Betnovate RD to your face You should only apply the cream to your face if your doctor tells you to. It should not be used for more than 5 days, as the skin on your face thins easily. Do not let the cream get into your eyes. If you use more Betnovate RD than you should If, by mistake on a few occasions you use more than you should, do not worry. If you continue to use too much over a period of time you may develop symptoms such as: stretch marks, the appearance of blood vessels under the surface of your skin, increased body hair, changes to the colour of your skin, skin thinning, weight gain, moon face/rounding of the face. If any of these symptoms occur or you think you have used too much of this medicine talk to your doctor or go to the hospital as soon as possible. If you forget to use Betnovate RD If you forget to apply your cream, apply it as soon as you remember. If it is close to the time you are next meant to apply it, wait until this time. If you stop using Betnovate RD If you use Betnovate RD regularly make sure you talk to your doctor before you stop using it. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4 Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop using Betnovate RD and tell your doctor as soon as possible if: you find that your skin condition gets worse or becomes swollen during treatment. You may be allergic to the Betnovate RD, have an infection or need other treatment. you have psoriasis and you get raised bumps with pus under the skin. This can happen very rarely during or after treatment and is known as pustular psoriasis. Other side effects you may notice when using Betnovate RD include: Common (affects less than 1 in 10 people)

local skin burning or pain itchy skin. Very rare (affects less than 1 in 10,000 people) Use of Betnovate for a long period of time, or use under an airtight dressing, may cause the following symptoms: increased weight rounding of the face / moon face obesity thinning of your skin, this may cause stretch marks and it may also damage more easily skin wrinkling skin dryness the appearance of blood vessels under the surface of your skin changes to the colour of your skin increased body hair hair loss / lack of hair growth / damaged looking hair Other very rare skin reactions that may occur are: allergic reaction at the site of application worsening of condition application site irritation (contact dermatitis) redness rash or hives skin infection In children also look out for the following symptoms: delayed weight gain slow growth Very rare side effects that may show up in blood tests or when your doctor gives you a medical examination: a decrease in the level of the hormone cortisol in your blood increased levels of sugar in your blood or urine high blood pressure cloudy lens in the eye (cataract) increased pressure in the eye (glaucoma) weakening of the bones through gradual loss of mineral (osteoporosis). Additional tests may be needed after your medical examination to confirm if you have this condition. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. 5 How to store Betnovate RD Keep this medicine out of the sight and reach of children. Do not use Betnovate RD after the expiry date which is stated on the tube end or carton after (Exp). The expiry date refers to the last day of that month.

Do not store above 25 o C. Store in the original package in order to protect from light. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw medicines you no longer use. These measures will help protect the environment. 6 Contents of the pack and other information What Betnovate RD cream contains The active ingredient is betamethasone. Each 1 g contains 0.25 mg of betamethasone (0.025% w/w) as valerate. The other ingredients are cetostearyl alcohol (see section 2), macrogol cetostearyl ether, white soft paraffin, liquid paraffin, chlorocresol (see section 2), disodium hydrogen phosphate, citric acid monohydrate and purified water. What Betnovate RD looks like and contents of the pack Within each carton is a tube with a plastic screw cap, which contains 100 g of cream. Marketing Authorisation Holder and Manufacturer Product Licence held by GlaxoSmithKline (Ireland) Ltd., 12 Riverwalk, Citywest Business Campus, Dublin 24. Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, Co. Durham DL12 8DT, UK This leaflet was last revised in July 2015 Other sources of information This package leaflet is available in formats that are suitable for the blind or partially sighted. Such formats are available on request. Betnovate is a registered trademark of the GlaxoSmithKline group of companies. 2015 GlaxoSmithKline group of companies